Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

11 results
Display

Renal Involvement in Rheumatic Diseases

Ahn SH, Jung JH

Most rheumatic diseases are chronic inflammatory diseases. Kidney-related symptoms of rheumatic diseases are often present, which increase mortality and morbidity of patients with rheumatic diseases. When patients with rheumatic diseases...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Autologous Haematopoietic Stem Cell Transplantation for Refractory Rheumatic Diseases

Park YB

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Augmentation Index in Connective Tissue Diseases

Choi JH, Kim J

Atherosclerosis and its complications are often reported in patients with connective tissue diseases (CTDs) showing chronic inflammation. Traditional cardiovascular risk factors do not account for accelerated atherosclerosis in patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multifocal Osteonecrosis in a Patient with Gout: Case Report and Review of the Literature

Kang SW, Lee CH

Osteonecrosis (ON) is a common comorbidity in gout; however, avascular ON of multiple sites is unusual. Multifocal ON is defined as osteonecrotic lesions affecting three or more separate anatomic sites....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cytoplasmic Anti-Neutrophil Cytoplasmic Antibody Positive Diffuse Alveolar Hemorrhage Associated with Methimazole

Ryu HS, Park JH, Sheen SS, Kim TH, Han SD, Jung JY, Suh CH, Hwang SC

Diffuse alveolar hemorrhage (DAH) is a life-threatening condition associated with many disorders. Here, we report a case of 59-year-old female who had diffuse alveolar hemorrhage associated with methimazole. She had...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative Efficacy and Safety of Secukinumab and Adalimumab in Patients with Active Ankylosing Spondylitis: A Bayesian Network Meta-analysis of Randomized Controlled Trials

Lee YH, Song GG

OBJECTIVE: This study assessed the efficacy and safety of secukinumab and adalimumab in patients with active ankylosing spondylitis (AS). METHODS: A Bayesian network meta-analysis was performed with direct and indirect data...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence and Risk Factors Associated with Neutropenia in Hospitalized Patients with Systemic Lupus Erythematosus

Chung MK, Kim IJ, Lee J

OBJECTIVE: This study estimated the prevalence and explored possible risk factors associated with neutropenia in hospitalized patients with systemic lupus erythematosus (SLE). METHODS: This review included 160 admissions of 85 SLE...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Polymyositis Associated with Immunoglobulin A Nephropathy

Oh YJ, Park ES, Jang M, Kang EW, Kie JH, Lee SW, Song JJ, Park YB, Lee CH, Park JS

Polymyositis (PM) is a chronic inflammatory disease that predominantly affects muscles. Systemic organ involvement, including the respiratory and gastrointestinal tracts, is frequently observed in PM, but renal involvement is rare....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk of Herpes Zoster in Patients with Rheumatoid Arthritis Undergoing Biologic Disease-Modifying Therapy

Kwon HM, Lee SJ, Yang JA, Choi Y, Park JK, Lee EY, Song YW, Lee EB

OBJECTIVE: Rheumatoid arthritis (RA) patients suffer from an increased risk of herpes zoster (HZ) partially due to immunosuppressant medications. This study investigated HZ in RA patients treated with biologic disease-modifying...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metabolomics Approach to Explore the Effects of Rebamipide on Inflammatory Arthritis Using Ultra Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry

Moon SJ, Lee SH, Jung BH, Min JK

OBJECTIVE: Rebampide is a gastroprotective agent used to treat gastritis. It possesses anti-inflammatory and anti-arthritis effects, but the mechanisms of these effects are not well understood. The objective of this...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparing Effectiveness Rituximab (Mabthera®) to Other Second-line Biologics for Rheumatoid Arthritis Treatment in Patients Refractory to or Intolerant of First-line Anti-tumor Necrosis Factor Agent: An Observational Study

Park YW, Kim KJ, Yang HI, Yoon BY, Kim SH, Kim SH, Kim J, Oh JS, Kim WU, Lee YA, Choe JY, Park MC, Lee SH

OBJECTIVE: Failure of first-line anti-tumor necrosis factor (TNF) agents in in rheumatoid arthritis patients leads to decisions among second-line biologic agents. To better inform these decisions, the therapeutic effectiveness of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr